The Effects of Monotherapy vs. Combination Therapy on Methicillin Resistant Staphylococcus aureus to Suppress Resistance
Overview
Objectives/Goals The objective is to study the optimum bactericidal effects of monotherapy versus combination therapy on MRSA by using the Kirby-Bauer method. Methods/Materials MRSA bacteria was inoculated to six agar plates. Positive battery test was used to dispense various antimicrobial discs: bactrim, cipro, clindamycin, erythromycin, gentamycin, nitrofuratoin, oxacillin as a control, vancomycin, synercid, and zyvox onto three plates. Three other nutrient agars were treated with the following combination antibiotics: vancomycin as a control, vancomycin plus bactrim, vancomycin plus cipro, vancomycin plus gentamycin, vancomycin plus synercid, and vancomycin plus zyvox. Note that the antibiotic combinations were placed side-by-side touching each other in the plates treated with combination therapy. After 18 hours of incubation, the zone of inhibitions were measured, tabulated, and graphed to elucidate the effects of different therapeutic regime with various antibiotics versus the radii of the zone of inhibition of MRSA growth. Results Combination antimicrobial therapy is superior to monotherapy in treating MRSA infection due to different mechanism of actions and synergistic effects. Conclusions/Discussion Combination therapy exhibits synergistic antimicrobial effects due to simultaneous assaults on the MRSA by deploying different mechanism of actions. Thus, combination antimicrobial therapy was proven to confer the optimum antimicrobial effects on Methicillin Resistant Staphylococcal aureus (MRSA) infection and thus prevail over resistance.
Summary statement
My project is to compare the antimicrobial effects of monotherapy versus combination therapy on MRSA growth.
Help received
I used the microbiology lab at Desert Medical Regional Center Hospital with the help of lab supervisor John Frazier and under the supervision of Dr. David Wong. In addition, great appreciation to Dr. Jolene Abraham and Dr. Bryan Hodgkin, director of Pharmacology Department for providing information.
Competition history
- CSEF 2009
Resources
Related projects
CSEF · 2005
Identification of a New Class of Antibiotics against MRSA
ISEF · 2026
Antibiotic Combinations as an Alternative Strategy Against Bacterial Resistance in Pseudomonas aeruginosa and Staphylococcus aureus
CSEF · 2017
Efficacy of Combinations of Plant-Based Antimicrobial Agents in Inhibiting the Growth of Antibiotic Resistant Bacteria
CSEF · 2015
The Effect of Increasing Colloidal Silver Concentrations in Combination with Vancomycin against B. cereus and E. coli
ISEF · 2023
Antimicrobial Resistance of a Biofilm-Forming Pathogen Probed With Antipyretic Pharmaceuticals and Antibiotics
CSEF · 2003
Using Earth Derived Antibiotics to Effectively Inhibit Staphylococcus aureus
ISEF · 2015
Developing an Effective Phage Therapy for Treatment of Methicillin-Resistant Staphylococcus aureus
CSEF · 2014
The Synergistic Effects of Antibiotics and Essential Oils
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects